Schafer F, Binder R, Bellolio E, Miranda R
Postepy Dermatol Alergol. 2022; 39(3):615-616.
PMID: 35950136
PMC: 9326917.
DOI: 10.5114/ada.2020.100820.
Baumer Y, McCurdy S, Boisvert W
Adv Biol (Weinh). 2021; 5(11):e2100638.
PMID: 34590446
PMC: 11055929.
DOI: 10.1002/adbi.202100638.
Francke M, Clahsen-van Groningen M, van den Bosch T, Becker J, Hesselink D
Transplant Direct. 2021; 7(7):e717.
PMID: 34476296
PMC: 8384396.
DOI: 10.1097/TXD.0000000000001158.
Hamura R, Haruki K, Iwase R, Furukawa K, Shirai Y, Onda S
Surg Case Rep. 2021; 7(1):45.
PMID: 33566211
PMC: 7876172.
DOI: 10.1186/s40792-021-01116-8.
Iseki K, Konta T, Asahi K, Yamagata K, Fujimoto S, Tsuruya K
Clin Exp Nephrol. 2020; 25(2):150-156.
PMID: 32960425
DOI: 10.1007/s10157-020-01971-z.
Atheroembolic Renal Disease.
Singh N, Gupta A, Kaur G
Indian J Nephrol. 2020; 30(1):1-2.
PMID: 32015591
PMC: 6977374.
DOI: 10.4103/ijn.IJN_382_18.
Atheroembolic Renal Disease: A Case Series.
Jansi Prema K, Kurien A
Indian J Nephrol. 2019; 29(6):427-430.
PMID: 31798227
PMC: 6883863.
DOI: 10.4103/ijn.IJN_265_18.
Renal cholesterol crystal embolism in the setting of warfarin use.
Munawar T, Ibe U, Jiwa N, Raissi S
BMJ Case Rep. 2019; 12(8).
PMID: 31439554
PMC: 6721062.
DOI: 10.1136/bcr-2019-230314.
Cholesterol-embolization syndrome: current perspectives.
Ozkok A
Vasc Health Risk Manag. 2019; 15:209-220.
PMID: 31371977
PMC: 6626893.
DOI: 10.2147/VHRM.S175150.
A rare presentation of spontaneous atheroembolic renal disease: A case report.
Piranavan P, Rajan A, Jindal V, Verma A
World J Nephrol. 2019; 8(3):67-74.
PMID: 31363463
PMC: 6656662.
DOI: 10.5527/wjn.v8.i3.67.
An atypical presentation of a severe and massive atheroembolic disease.
Falcao L, Fernandes S, Costa A, Teixeira C, Raimundo M, Silva S
J Bras Nefrol. 2018; 41(1):142-144.
PMID: 30129967
PMC: 6534016.
DOI: 10.1590/2175-8239-JBN-2018-0013.
Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment.
Wang Y, Bellomo R
Nat Rev Nephrol. 2017; 13(11):697-711.
PMID: 28869251
DOI: 10.1038/nrneph.2017.119.
Cholesterol Crystal Embolism and Chronic Kidney Disease.
Li X, Bayliss G, Zhuang S
Int J Mol Sci. 2017; 18(6).
PMID: 28538699
PMC: 5485944.
DOI: 10.3390/ijms18061120.
Efficacy of low-density lipoprotein apheresis combined with corticosteroids for cholesterol crystal embolism.
Ishiyama K, Sato T, Yamaguchi T, Taguma Y
Clin Exp Nephrol. 2016; 21(2):228-235.
PMID: 27101825
DOI: 10.1007/s10157-016-1272-x.
A Study of Relationship of Atheroembolic Risk Factors with Postoperative Recovery in Renal Function after Partial Nephrectomy in Patients Staged T1-2 Renal Cell Carcinoma during Median 4-Year Follow-up.
Kim S, Kang K, Yu A, Lee J, Nam B, Lee E
Cancer Res Treat. 2015; 48(1):288-96.
PMID: 25943322
PMC: 4720065.
DOI: 10.4143/crt.2014.297.
Blue toe in a male with cholesterol embolisation syndrome.
Arakawa K, Konoshita T, Makino Y, Ishizuka T
Clin Med (Lond). 2014; 14(6):688-9.
PMID: 25468862
PMC: 4954149.
DOI: 10.7861/clinmedicine.14-6-688.
Low-density lipoprotein apheresis ameliorates monthly estimated glomerular filtration rate declines in patients with renal cholesterol crystal embolism.
Hirai K, Ookawara S, Miyazawa H, Ito K, Ueda Y, Kaku Y
J Artif Organs. 2014; 18(1):72-8.
PMID: 25367276
DOI: 10.1007/s10047-014-0801-1.
Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group.
Ohno I, Hayashi H, Aonuma K, Horio M, Kashihara N, Okada H
Clin Exp Nephrol. 2013; 17(4):441-79.
PMID: 23896863
DOI: 10.1007/s10157-013-0843-3.
Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group.
Ohno I, Hayashi H, Aonuma K, Horio M, Kashihara N, Okada H
Jpn J Radiol. 2013; 31(8):546-84.
PMID: 23884513
DOI: 10.1007/s11604-013-0226-4.
Favorable outcome in atheroembolic renal disease with pulse steroid therapy.
Sharma A, Hada R, Agrawal R, Baral A
Indian J Nephrol. 2013; 22(6):473-6.
PMID: 23439923
PMC: 3573493.
DOI: 10.4103/0971-4065.106056.
